April 7, 2014
Daiichi Sankyo said on April 7 that major Indian generic maker Sun Pharmaceutical Industries will acquire its Indian subsidiary Ranbaxy Laboratories in a share swap deal. Under the deal, Daiichi Sankyo’s entire 63.4% stake in Ranbaxy will be transferred to...read more